Should I take rivaroxaban or dabigatran etexilate capsules (Pradaxa) for atrial fibrillation?

When patients with atrial fibrillation choose anticoagulant drugs, they usually face the choice of two oral anticoagulants, rivaroxaban and dabigatran etexilate capsules (Pradaxa). These two drugs are direct thrombin inhibitors used to prevent stroke and thromboembolism. The following are some considerations for patients with atrial fibrillation taking rivaroxaban or dabigatran etexilate capsules:

Rivaroxaban (Rivaroxaban):

1.Once-a-day administration: Rivaroxaban is usually taken orally once a day, which makes the medication more convenient for patients.

2.Widely used: Rivaroxaban is widely used in patients with atrial fibrillation, has a long history of use, and its efficacy has been verified to a certain extent.

3.Specific indications: Rivaroxaban is also approved for the treatment of deep vein thrombosis and pulmonary embolism, and also has certain applications in anticoagulation therapy after surgery.

Dabigatran etexilate capsules (Pradaxa):

1.Two dosage options: Dabigatran etexilate capsules have two common dosages, namely 110mg and 150mg, which can be personalized according to the patient's specific conditions.

2.Fast anticoagulant effect: The anticoagulant effect of dabigatran etexilate capsules is relatively fast, which may be an advantage in some situations where rapid control of anticoagulation levels is required.

3.Indications: Dabigatran etexilate capsules are mainly used for the prevention of stroke in patients with non-valvular atrial fibrillation and the treatment of deep vein thrombosis and pulmonary embolism.

When choosing between rivaroxaban and dabigatran etexilate capsules, doctors usually consider the patient's individual situation, including age, renal function, drug interactions and other factors. At the same time, the patient's personal preferences, convenience of medication, and drug cost may also affect the choice.

Dabigatran etexilate capsules have been launched in China and have been included in medical insurance. Patients can purchase them domestically. Please consult the local hospital pharmacy for specific prices. The main foreign drug is the original drug of dabigatran etexilate capsules. The cheaper one is the Turkish version of the original drug from Germany. The price of 110mg*60 capsules is about three to four hundred, and the ingredients and efficacy are consistent with the original drug on the domestic market.